...
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Early Surgical Intervention for Femoroacetabular Impingement Syndrome Provides Clinically Significant Outcome Improvement
【24h】

Early Surgical Intervention for Femoroacetabular Impingement Syndrome Provides Clinically Significant Outcome Improvement

机译:髋臼前突综合征的早期外科手术治疗可提供临床上显着的改善效果

获取原文

摘要

Objectives: The purpose of the current study is to assess the outcomes of hip arthroscopy for FAIS according-timing of surgical intervention. Methods: Patients undergoing arthroscopic intervention for FAIS with minimum two year follow-up were included. All patients completed the hip outcome score (HOS)-activities of daily living (ADL), HOS-sports subscale (HOS-SS), modified Harris hip score (mHHS), international hip outcome tool-12 (IHOT-12), and visual analog scales (VAS) for pain and satisfaction. Patients were stratified by time with FAIS symptoms until surgical intervention. We compared 3-6 months of symptoms with other subsequent time frames (6-12 months, 12-24 months, and &24 months). Clinically significant outcome was determined using the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS). Results: A total of 1,094 patients with mean (+ standard deviation) age 32.3+12.4 years and follow-up 30.8+6.7 (range:24-58) months were included. Patients undergoing surgery at 3-6 months of symptoms had no significant differences in outcome compared-those in the 6-12 month group except for the IHOT-12 (p:0.028). Patients with symptom duration of 12-24 months and greater than 24 months had worse outcome across all outcome measures (p&0.0001 for symptoms &24 months). Patients in the 3-6 month symptom group had increased likelihood for achieving MCID on HOS ADL (OR:1.81; 1.20-2.73), and HOS-SS (OR:1.90; 1.11-3.17), as well as PASS on the HOS-ADL (OR:1.85; 1.34-2.56) and HOS-SS (OR:1.58; 1.14-2.18). In multivariate regression analysis, symptom duration was the most predictive of VAS pain (Beta:3.10, 95% Confidence Interval [95%CI]:1.56-4.63; p&0.001) and satisfaction scores (Beta:-4.16, 95%CI:-6.14- -2.18; p&0.001). Conclusion: In patients with FAIS, surgical intervention early after the onset of symptoms (3-6 months) is associated with superior outcomes when compared to patients who underwent surgical intervention beyond this time frame. This information may help guide preoperative decision making on behalf of surgeons and patients who are considering delaying intervention. Table 1. MCID and PASS rates stratified by hip arthroscopy timing 3-6 months 6-12 months 12-24 months &24 months p-value (MCID) p-value (PASS) MCID PASS MCID PASS MCID PASS MCID PASS HOS-ADL 81.3% 72.8% 77.8% 67.8% 75.4% 65.0% 64.6% 55.1% &0.001 &0.001 HOS-SS 89.8% 69.2% 85.7% 62.4% 81.0% 62.6% 77.4% 53.1% &0.001 &0.001 mHHS 85.9% 77.6% 83.4% 74.6% 83.1% 71.7% 72.2% 65.2% &0.001 &0.001 Δ score indicates 2-year change in patient reported outcome score. MCID: Minimal clinically important difference PASS: Patient acceptable symptomatic state
机译:目的:本研究的目的是根据手术干预的时机评估髋关节镜检查对FAIS的疗效。方法:纳入接受关节镜介入治疗的FAIS患者,至少随访两年。所有患者均完成日常生活活动的髋关节预后评分(HOS)-活动(ADL),HOS-运动子量表(HOS-SS),改良的Harris髋关节评分(mHHS),国际髋关节预后工具12(IHOT-12)和视觉模拟量表(VAS)带来的疼痛和满足感。患者按FAIS症状的时间进行分层,直到进行手术干预为止。我们将3-6个月的症状与其他随后的时间范围(6-12个月,12-24个月和> 24个月)进行了比较。使用最小的临床重要差异(MCID)和患者可接受的症状状态(PASS)确定临床上显着的结果。结果:共纳入1,094例平均(+标准差)年龄32.3 + 12.4岁且随访30.8 + 6.7(范围:24-58)个月的患者。在3-6个月症状时接受手术的患者与6-12个月组相比,结果没有显着差异,除了IHOT-12(p:0.028)。症状持续时间为12-24个月且大于24个月的患者在所有结局指标中的结局均较差(症状> 24个月,p <0.0001)。 3-6个月症状组的患者在HOS ADL(OR:1.81; 1.20-2.73)和HOS​​-SS(OR:1.90; 1.11-3.17)上获得MCID的可能性增加,在HOS- ADL(OR:1.85; 1.34-2.56)和HOS​​-SS(OR:1.58; 1.14-2.18)。在多元回归分析中,症状持续时间最能预测VAS疼痛(β:3.10,95%置信区间[95%CI]:1.56-4.63; p <0.001)和满意度评分(β:-4.16,95%CI: -6.14--2.18; p <0.001)。结论:在FAIS患者中,与在此时间段之后接受手术干预的患者相比,在症状发作后早期(3-6个月)进行手术干预具有更好的预后。此信息可能有助于指导正在考虑延迟干预的外科医生和患者进行术前决策。表1.按髋关节镜检查时间分层的MCID和通过率3-6个月6-12个月12-24个月> 24个月p值(MCID)p值(PASS)MCID合格MCID合格MCID合格MCID合格HOS- ADL 81.3%72.8%77.8%67.8%75.4%65.0%64.6%55.1%& 0.001& 0.001 HOS-SS 89.8%69.2%85.7%62.4%81.0%62.6%77.4%53.1%& 0.001& 0.001 mHHS 85.9 %77.6%83.4%74.6%83.1%71.7%72.2%65.2%& 0.001& 0.001Δ评分表示患者报告的结局评分的2年变化。 MCID:最小的临床重要差异PASS:患者可接受的症状状态

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号